Eyenovia Inc (EYEN)
1.000
+0.07
(+7.35%)
USD |
NASDAQ |
May 03, 16:00
1.04
+0.04
(+3.95%)
After-Hours: 16:25
Eyenovia Profit Margin (Quarterly): -307.7K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -307.7K% |
| September 30, 2023 | -612.6K% |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 |
| Date | Value |
|---|---|
| March 31, 2022 | |
| December 31, 2021 | 29.83% |
| September 30, 2021 | |
| June 30, 2021 | -242.1% |
| March 31, 2021 | -267.6% |
| December 31, 2020 | -210.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-612.6K%
Minimum
Sep 2023
29.83%
Maximum
Dec 2021
-153.5K%
Average
-254.8%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Alpine Immune Sciences Inc | 19.32% |
| Lantern Pharma Inc | -- |
| Oragenics Inc | -- |
| MAIA Biotechnology Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -199.4% |
| Return on Assets | -88.89% |
| Return on Invested Capital | -105.7% |
| Operating Margin (Quarterly) | -288.4K% |
| Return on Net Operating Assets | -332.0% |